We are live on ! Find out more
PDSB icon

PDS Biotechnology
PDSB

77 hedge funds and large institutions have $42M invested in PDS Biotechnology in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 17

6% more capital invested

Capital invested by funds: $39.7M → $42M (+$2.28M)

1.65% more ownership

Funds ownership: 25.47% → 27.11% (+1.6%)

7% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 15

1% less funds holding

Funds holding: 78 → 77 (-1)

55% less call options, than puts

Call options by funds: $1.04M | Put options by funds: $2.31M

Holders
77
Holders Change
-1
Holders Change %
-1.28%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
26
Reduced
17
Closed
15
Calls
$1.04M
Puts
$2.31M
Net Calls
-$1.28M
Net Calls Change
-$1.32M

Top Buyers

Rank Fund Capital Flow
1
JFG
Jefferies Financial Group
New York
+$1.99M
2
Renaissance Technologies
Renaissance Technologies
New York
+$600K
3
Morgan Stanley
Morgan Stanley
New York
+$504K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$401K
5
BlackRock
BlackRock
New York
+$388K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
-$707K
2
LPL Financial
LPL Financial
California
-$513K
3
Two Sigma Investments
Two Sigma Investments
New York
-$433K
4
Marshall Wace
Marshall Wace
United Kingdom
-$347K
5
TI
Trexquant Investment
Connecticut
-$131K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$9.35M +$388K +77,955 +4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$7.48M -$10K -2,020 -0.1%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$3.15M +$158K +31,844 +5%
State Street
4
State Street
Massachusetts
$2.74M +$234K +47,091 +9%
TCM
5
Tang Capital Management
California
$1.99M – – –
JFG
6
Jefferies Financial Group
New York
$1.99M +$1.99M +400,000 New
IWA
7
Inspirion Wealth Advisors
Illinois
$1.73M +$28.4K +5,720 +2%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$1.3M +$401K +80,681 +45%
Northern Trust
9
Northern Trust
Illinois
$1.24M +$16.5K +3,311 +1%
Morgan Stanley
10
Morgan Stanley
New York
$846K +$504K +101,474 +147%
SI
11
Sofinnova Investments
California
$709K – – –
LPL Financial
12
LPL Financial
California
$654K -$513K -103,250 -44%
Citadel Advisors
13
Citadel Advisors
Florida
$648K +$171K +34,393 +36%
Renaissance Technologies
14
Renaissance Technologies
New York
$600K +$600K +120,700 New
Two Sigma Advisers
15
Two Sigma Advisers
New York
$542K -$707K -142,300 -57%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$535K -$5.39K -1,084 -1%
N
17
Nuveen
North Carolina
$523K – – –
Bank of America
18
Bank of America
North Carolina
$422K +$273K +54,889 +183%
Charles Schwab
19
Charles Schwab
California
$384K – – –
Commonwealth Equity Services
20
Commonwealth Equity Services
Massachusetts
$383K +$51.8K +10,429 +16%
IGGA
21
Iron Gate Global Advisors
Utah
$373K – – –
Group One Trading
22
Group One Trading
Illinois
$264K +$59.6K +11,994 +29%
Mirae Asset Global Investments
23
Mirae Asset Global Investments
South Korea
$256K – – –
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$247K +$247K +49,695 New
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$210K -$9.83K -1,978 -4%
1
2 3 4

PDSB Hedge Fund Activity: Q4 2023 in Review

77 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q4 2023, worth a combined $42M — up 5.7% from $39.7M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of PDSB and 14 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 26 added.

The largest buyer was Jefferies Financial Group, opening a new position worth an estimated $1.99M. The largest seller was Two Sigma Advisers, cutting an estimated $707K.

  • 77 institutional investors held PDS Biotechnology (PDSB) as of Q4 2023, down from 78 in Q3 2023.
  • Funds reported $42M of PDS Biotechnology stock for Q4 2023, up 5.7% quarter-over-quarter.
  • 14 funds opened new PDS Biotechnology positions in Q4 2023 and 15 closed out, a net change of -1 holder.
  • The largest PDS Biotechnology buyer in Q4 2023 was Jefferies Financial Group, an estimated $1.99M added.
  • The largest PDS Biotechnology seller in Q4 2023 was Two Sigma Advisers, an estimated $707K sold.

Based on aggregated 13F filings for Q4 2023.